Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial

By M. Lind, W. Polonsky, I. Hirsch, T. Heise, J. Bolinder, S. Dahlqvist, E. Schwarz, A. F. Ólafsdóttir, A. Frid, H. Wedel and 3 more. Journal of the American Medical Association (JAMA), 2017

653 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, General Health Professions

View Paper: https://www.semanticscholar.org/paper/4954b7d4918dac76865532d2c6c358e4b78e09ae

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. Boris P. Kovatchev
2. Eric Renard
3. Claudio Cobelli
4. J. Hans DeVries
5. I. Hirsch
6. D. Rodbard
7. Chao Yu
8. Jiming Liu

Citations in the corpus

• Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range (2019, background): “A1C is currently recognized as the key surrogate marker for the development of long-termdiabetes complications in people with type 1 and type 2 diabetes and has been used as the primary end point for many CGM studies (1,3,4,6,33,34).”